Authorized Generics: Launches And Promises
You may also be interested in...
Authorized Generics Do Not Deter Patent Challenges, FTC Says, But May Be Used To Delay Competition
Authorized generics modestly reduce drug prices during the first 180 days of generic competition and substantially undercut the revenues of competing generic firms, according to the Federal Trade Commission.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.